These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Getting real about valuations in biotech. Villiger R, Bogdan B. Nat Biotechnol; 2005 Apr; 23(4):423-8. PubMed ID: 15815665 [No Abstract] [Full Text] [Related]
10. Overcoming further challenges in the pharma/biotech industry: 2007 update. Graul AI, Cruces E, Revel L, Serradell N, Rosa E. Drug News Perspect; 2008 Apr; 21(1):44-58. PubMed ID: 18301809 [Abstract] [Full Text] [Related]
11. The number on biotech indexes. Jacobs T. Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059 [No Abstract] [Full Text] [Related]
13. Biotech acquisitions by big pharma: why and what is next. Malik NN. Drug Discov Today; 2009 Sep; 14(17-18):818-21. PubMed ID: 19584004 [Abstract] [Full Text] [Related]
14. Little biotech on the prairie. Wolfson W. Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626 [No Abstract] [Full Text] [Related]
15. Profiles of four top biotech companies in India. Suresh N, Rao ChS. Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435 [No Abstract] [Full Text] [Related]
16. Biotech slumps in Q1. Lawrence S. Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769 [No Abstract] [Full Text] [Related]
17. Editorial: Biotech in the financial crisis. Jungbauer A. Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457 [No Abstract] [Full Text] [Related]